目录产品 » 稳定细胞系 » Human Recombinant SST5 Somatostatin Receptor Stable Cell Line
CHO-K1/SST5/Gα15 Stable Cell Line

Figure 1. Somatostatin-14-induced concentration-dependent stimulation of intracellular calcium mobilization in CHO-K1/SST5/Gα15 cells. The cells were loaded with Calcium-4 (Cat. No. R8142; Molecular Devices) prior to stimulation with SST5 agonist, somatostatin-14. The intracellular calcium change was measured by FLIPRTETRA. The relative fluorescent units (RFU) were recorded and normalized to plot against the log of the cumulative doses of somatostatin-14 (mean ± SEM, n = 3). The EC50 of somatostatin-14 on CHO-K1/SST5/Gα15 cells was 0.35 μM.

Notes:
EC50 value is calculated with four parameter logistic equation:
Y=Bottom + (Top-Bottom) / (1+10^ ((LogEC50-X)*Hill Slope))
X is the logarithm of concentration. Y is the response. Y is % stimulation of RFU and starts at Bottom and goes to Top along a sigmoid curve.

CHO-K1/SST5/Gα15 Stable Cell Line

Figure 2. Dose dependent stimulation of intracellular IP-One accumulation upon treatment with somatostatin-14 in CHO-K1/SST5/Gα15 cells. d2 acceptor fluorophore-labeled IP-One (Cat. No. 62IPAPEB; Revvity) and intracellular IP-One in CHO-K1/SST5/Gα15 cells competitively bind with Europium Cryptate-labeled anti-IP-One antibody. The FRET signal decreases as the intracellular IP-One concentration rises and was measured by plate reader (Pherastar, BMG). The EC50 of somatostatin-14 on CHO-K1/SST5/Gα15 cells was 0.19 μM.

CHO-K1/SST5/Gα15 Stable Cell Line

Recombinant CHO-K1 cells stably overexpress human somatostatin receptor 5 (SST5) on the surface and contain high levels of G protein Gαi to couple with the receptor in downstream signaling pathways.
M00286
询价

联系我们
Product Description Recombinant CHO-K1 cells stably overexpress human somatostatin receptor 5 (SST5) on the surface and contain high levels of G protein Gαi to couple with the receptor in downstream signaling pathways.
Applications Calcium flux assay, IP-One assay and cAMP accumulation assay.

Expressed Gene NCBI reference sequence NM_001053; no expressed tags
Target Protein NP_001044
Host Cell CHO-K1
Size Two vials of frozen cells (>1×106 per vial in 1 mL)
Storage Store cells in liquid nitrogen immediately upon receipt. Thaw and recover cells within one year from the date received.
Mycoplasma Status Negative. The mycoplasma test was performed with MycoAlert™ PLUS Mycoplasma Detection Kit (Cat. No. LT07-318, Lonza).
Stability Stable through more than 16 passages with no significant changes in assay performance or expression profile.

Culture Properties Adherent
Freeze Medium 45% Ham’s F-12K (Kaighn’s) (Cat. No. 21127, Life Technologies), 45% FBS (Cat. No. 10099-141, Life Technologie s), 10% DMSO (Cat. No. D2650, Sigma)
Complete Growth Medium Ham’s F-12K (Kaighn’s), 10% FBS
Culture Medium Ham’s F-12K (Kaighn’s), 10% FBS, 200 μg/ml Zeocin (Cat. No. R250-01, Life Technologies), 100 μg/ml Hygromycin B (Cat. No. 10687010, Life Technologies)

Gene Synonyms SS-5-R, SST5R
Background Somatostatin receptors (SSTRs), a family of seven transmembrane (TM) domain G-protein-coupled receptors having five distinct subtypes (termed SSTR1–5), are activated by somatostatin secreted from the nerve and endocrine cells. SSTRs are widely expressed in many tissues, frequently as multiple subtypes that coexist in the same cell. With expressions in a tissue-specific manner, SSTRs are involved in the regulation of secretion of insulin, glucagon and growth hormone as well as cell growth induced by neuronal excitation in both the central and peripheral nervous systems. The five receptors share common signaling pathways such as the inhibition of adenylyl cyclase, activation of phosphotyrosine phosphatase (PTP), and modulation of mitogen-activated protein kinase (MAPK) through G-protein-dependent mechanisms. Aberrant expression of somatostatin receptors is known to be involved in a large number of human tumors.

  • CHO-K1/SST5/Gα15 Stable Cell Line
  • CHO-K1/SST5/Gα15 Stable Cell Line

    Figure 1. Somatostatin-14-induced concentration-dependent stimulation of intracellular calcium mobilization in CHO-K1/SST5/Gα15 cells. The cells were loaded with Calcium-4 (Cat. No. R8142; Molecular Devices) prior to stimulation with SST5 agonist, somatostatin-14. The intracellular calcium change was measured by FLIPRTETRA. The relative fluorescent units (RFU) were recorded and normalized to plot against the log of the cumulative doses of somatostatin-14 (mean ± SEM, n = 3). The EC50 of somatostatin-14 on CHO-K1/SST5/Gα15 cells was 0.35 μM.

    Notes:
    EC50 value is calculated with four parameter logistic equation:
    Y=Bottom + (Top-Bottom) / (1+10^ ((LogEC50-X)*Hill Slope))
    X is the logarithm of concentration. Y is the response. Y is % stimulation of RFU and starts at Bottom and goes to Top along a sigmoid curve.

  • CHO-K1/SST5/Gα15 Stable Cell Line
  • CHO-K1/SST5/Gα15 Stable Cell Line

    Figure 2. Dose dependent stimulation of intracellular IP-One accumulation upon treatment with somatostatin-14 in CHO-K1/SST5/Gα15 cells. d2 acceptor fluorophore-labeled IP-One (Cat. No. 62IPAPEB; Revvity) and intracellular IP-One in CHO-K1/SST5/Gα15 cells competitively bind with Europium Cryptate-labeled anti-IP-One antibody. The FRET signal decreases as the intracellular IP-One concentration rises and was measured by plate reader (Pherastar, BMG). The EC50 of somatostatin-14 on CHO-K1/SST5/Gα15 cells was 0.19 μM.


For research use only. Not intended for human or animal clinical trials, therapeutic or diagnostic use.


喜欢新升级的网站吗?

讨厌

不喜欢

一般

喜欢

非常喜欢

*